Sales $2m , Staff costs $4m for the quarter! How can you justify this?
No major revenues forecast until 2025 and reliant on FDA approvals.
CEO needs to step up and make some tough decisions on this company moving forward.
Pathetic, and no accountability!
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-3
Add GSS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
73.0¢ |
Change
0.010(1.39%) |
Mkt cap ! $136.1M | |||
| Open | High | Low | Value | Volume |
| 67.0¢ | 74.0¢ | 67.0¢ | $101.8K | 143.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 18000 | 67.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 73.5¢ | 1248 | 1 |
View Market Depth
| Last trade - 16.10pm 29/05/2024 (20 minute delay) ? |
|
|||||
|
Last
73.0¢ |
Change
0.010 ( 1.39 %) |
||||
| Open | High | Low | Volume | ||
| 69.5¢ | 73.0¢ | 69.5¢ | 11543 | ||
| Last updated 15.03pm 29/05/2024 ? | |||||
| GSS (ASX) Chart |